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It has long been thought that mammalian Sertoli cells are terminally differentiated and nondividing postpu-
berty. For most previous in vitro studies immature rodent testes have been the source of Sertoli cells and
these have shown little proliferative ability when cultured. We have isolated and characterized Sertoli cells
from human cadaveric testes from seven donors ranging from 12 to 36 years of age. The cells proliferated
readily in vitro under the optimized conditions used with a doubling time of approximately 4 days. Nuclear
5-ethynyl-2′-deoxyuridine (EdU) incorporation confirmed that dividing cells represented the majority of the
population. Classical Sertoli cell ultrastructural features, lipid droplet accumulation, and immunoexpression
of GATA-4, Sox9, and the FSH receptor (FSHr) were observed by electron and fluorescence microscopy,
respectively. Flow cytometry revealed the expression of GATA-4 and Sox9 by more than 99% of the cells,
and abundant expression of a number of markers indicative of multipotent mesenchymal cells. Low detection
of endogenous alkaline phosphatase activity after passaging showed that few peritubular myoid cells were
present. GATA-4 and SOX9 expression were confirmed by reverse transcription polymerase chain reaction
(RT-PCR), along with expression of stem cell factor (SCF), glial cell line-derived neurotrophic factor
(GDNF), and bone morphogenic protein 4 (BMP4). Tight junctions were formed by Sertoli cells plated on
transwell inserts coated with fibronectin as revealed by increased transepithelial electrical resistance (TER)
and polarized secretion of the immunoregulatory protein, galectin-1. These primary Sertoli cell populations
could be expanded dramatically in vitro and could be cryopreserved. The results show that functional human
Sertoli cells can be propagated in vitro from testicular cells isolated from adult testis. The proliferative
human Sertoli cells should have important applications in studying infertility, reproductive toxicology, testic-
ular cancer, and spermatogenesis, and due to their unique biological properties potentially could be useful
in cell therapy.
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INTRODUCTION half of the differentiating germ cells that undergo apo-
ptosis.
The BTB that is formed by tight junctions betweenSomatic Sertoli cells are the main structural compo-
nent of the seminiferous tubule, create the blood–testis the Sertoli cells is thought to limit the access of nutri-
ents, hormones, and other biological substances to thebarrier (BTB), and perform multiple functions that are
required for the remarkable cellular transformation of adluminal compartment of the seminiferous tubule, and
to physically shield the postmeiotic germ cells from thespermatogonial stem cells into haploid cells and then
into spermatozoa (22). Although often termed “mother” immune system (64,87). Sertoli cell expression of vari-
ous mediators also is thought to create a localized immu-or “nurse” cells because of their role in nurturing the
developing germ cells, Sertoli cells also are important nosuppressive effect within the testis (18,59). The ability
of Sertoli cells to modulate immune responses has beenas phagocytes of the residual cytoplasm of more than
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studied by cotransplanting them with other cells at ec- protocol was a modification of a previously described
method (39), and was approved by the Committee ontopic sites, where Sertoli cells were found to protect and
extend survival of such grafts (16,37,56,59,68). Human Research, University of California (San Fran-
cisco, CA, USA). All reagents and materials were han-During fetal and early postnatal development in mice,
the transcription factor GATA-4, a zinc finger protein dled aseptically. The testis was washed with ice-cold
calcium/magnesium free Hanks balanced salt solutionimplicated in regulation of gene expression and cellular
differentiation, is expressed in the Sertoli and Leydig (HBSS) containing 100 U/ml penicillin and 100 µg/ml
streptomycin, and then all of the skin and the tunica al-cells but not germ cells (34,38,79). Another protein ex-
pressed by immature and mature Sertoli cells is Sox9 buginea were removed. The tissue was rinsed again with
HBSS, minced, transferred to a 1-L Erlenmeyer flask,(30,35,36). Sox9 (34) and FSHr (4) are both exclusively
expressed by Sertoli cells in the testis. Sox9 is a Sry- and washed three times with HBSS. After the final
wash, the tissue was covered with HBSS, transferred tobox-containing gene encoding a transcriptional activator
that has been found to suffice for testis formation in a 37°C water bath, and shaken at 275–325 rpm for 15
min. Again, the tissue was allowed to settle, and themice (33), is essential for Sertoli cell differentiation
(20,30,45,46), and has been used to identify Sertoli cells supernatant was discarded, and 100 ml of HBSS con-
taining 0.25% trypsin (Sigma, St. Louis, MO, USA), andin transplantation studies (25). Immunoreactivity has
shown that human Sertoli cells produce GDNF, which 0.1% collagenase type IV (Sigma) was added. The flask
was shaken at 275–325 rpm in a water bath at 37°C foris thought to aid in the self-renewal of spermatogonial
stem cells (11,26), and immunohistochemical analyses 20 min, the solution was strained through a coarse wire
mesh (1 mm2) and the flow-through stored on ice. Ifalso have shown that galectin-1 is expressed by rat (13)
and human Sertoli cells (83). undigested tissue remained, the digestion was repeated.
Finally, 0.034% of soybean trypsin inhibitor (Sigma)It has long been thought to be a fact that mammalian
Sertoli cells do not divide postpuberty (49,62). For many was added, the homogenate was passed through a sy-
ringe with an 18-gauge needle, and then centrifuged atin vitro studies, testes from immature 20-day-old rodent
pups have been the source of Sertoli cells (77) and these 800 × g for 5 min. The cell pellet was suspended in
DMEM/F-12 Hams medium [1:1; Cell Culture Facility,have shown little proliferative ability. The rodent Sertoli
cells have been thought to cease dividing by postnatal University of California, San Francisco (UCSF)], con-
taining penicillin and streptomycin, with 5% FBS, andday 15–17 when the BTB is being established (8). We
unexpectedly discovered (75) that human Sertoli cells plated in a T-225 flask. The cells were propagated in
the same medium and incubated at 37°C in a 5% CO2from adult humans regain proliferative ability in vitro
using standard cell culture conditions and medium con- incubator. Cells were dissociated using Cell Dissociation
Buffer (Invitrogen, Carlsbad, CA, USA) and trypsintaining fetal bovine serum (FBS) but no other additives
such as hormones or gonadotropins. Our findings are (0.05%) with EDTA.
supported by those of Ahmed et al. (1), who reported
Ultrastructural Analysis by Transmissionthat Sertoli cells isolated from the adult mouse and hu-
Electron Microscopyman testis resume proliferation in culture in the absence
of hormonal supplementation. Cells at 70–80% confluence were rinsed with 0.1 M
sodium cacodylate buffer, pH 7.4, and fixed with buf-Because there is interest in using Sertoli cells to mini-
mize transplant rejection due to their inherent immuno- fered 2% glutaraldehyde. Samples, collected by scraping
the dishes, were pelleted at 800 × g for 2 min, and post-logical suppressive properties (17,61), establishing con-
ditions to produce proliferative human Sertoli cells in fixed with 1% osmium tetroxide. Pelleted cells were de-
hydrated in graded ethanol solutions, infiltrated, and em-vitro could facilitate research on their use for therapeutic
applications, such as in cell or organ transplantation. In bedded in Epon-Araldite-812 (Electron Microscopy
Science, Fort Washington, PA, USA). Sections were cutthis study, we specifically aimed to reproducibly isolate,
and expand primary adult human Sertoli cells from ca- at 70-nm thickness using a diamond knife, stained with
uranyl acetate and lead citrate, and imaged at 4,000–daveric testes, and then to characterize the cells and to
determine their functionality in vitro. 25,000 magnification on a Zeiss EM 10C Electron 5 mi-
croscope.
MATERIALS AND METHODS
Immunocytochemical AnalysisIsolation and Culture of Human Sertoli Cells
Seven deceased individuals (12–36 years of age) Sertoli cells were grown on glass chamber slides
(LabTek II, Nunc; Thermo Fisher, Rochester, NY, USA)were donors of testicular tissue that was obtained from
the National Disease Research Interchange (NDRI, Phil- and fixed with methanol at −80°C for 1 h or 4% para-
formaldehyde (PFA) at room temperature (RT) for 30adelphia, PA, USA) within 36 h of death. The isolation
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min. After washing with phosphate-buffered saline ing efficiency was determined by quantifying nonviable
floating cells after 72 h in cell culture media. The divi-(PBS), the cells were blocked and permeabilized by in-
cubation in 2–5% normal serum in PBS with 0.1–0.2% sion rate was calculated by plating (4.5 × 102 cells/cm2)
and quantifying cells over nine or more divisions to de-Triton X-100 at RT for 1 h. Cells were incubated with
primary antibodies (Table 1) that were diluted in block- termine an average rate. In addition, the division rate
and contact inhibition were examined by quantifying theing buffer at 4°C overnight. Dye-conjugated secondary
antibodies were diluted in blocking buffer, and incu- increase in metabolically active cells plated in 96-well
plates over a 48-h period.bated at RT for 1 h. The controls were: cells without
antibody, secondary antibody alone, and nonspecific
Detection of Proliferation by IncorporationIgG (control for primary antibody) with secondary anti-
of 5-Ethynyl-2′-Deoxyuridinebody. Cell nuclei were stained with bisbenzamide (In-
vitrogen, 2 µg/ml) for 2 min, washed with PBS, and To evaluate cell proliferation, 3.6 × 104 cells were
added to each well of a four-well chamber slide, andmounted using Aqua-Mount (Biomeda, Foster City, CA,
USA). Images from fluorescence microscopy were cap- allowed to attach overnight. Cells were incubated with
2 µM 5-ethynyl-2′-deoxyuridine (EdU) in 0.5 ml me-tured with NIS-Elements v.2 software with cooled CCD
camera, with image processing and pseudocolor en- dium at 37°C in a 5% CO2 incubator for 3 days. The
cells were washed twice with HBSS, allowed to recoverhancement of contrast (Photoshop, Adobe, San Jose,
CA, USA or ImageJ). overnight, and then fixed in methanol at −80°C over-
night. The cells were blocked by washing twice with 5%
Cell Expansion and Storage normal goat serum in PBS, permeabilized in 0.5%
Tween-20 in PBS at RT for 20 min, and then washedFor expansion, viable cells were counted by trypan
blue exclusion using a hemacytometer, seeded (1 × 105 twice with blocking buffer. For detection, 150 µl of the
Alexa-Fluor 594-conjugated azide cocktail (Invitrogen)cells) in a T-225 tissue culture flask, and propagated in
DMEM/F-12 Hams medium (1:1; Cell Culture Facility, was added (per the manufacturer’s instructions) per well
and the slide rocked in the dark at RT for 30 min. CellsUCSF) with 5% FBS in a 5% CO2 incubator at 37°C.
When 80–90% confluent, cells were harvested with Cell were washed twice before the slides were mounted.
Dissociation Buffer (Invitrogen) and trypsin (0.05%)
Lipid Droplet Staining of Sertoli Cellswith EDTA, and stored in liquid nitrogen in dimethyl
sulfoxide-containing Cell Preservation Media (Cell Cul- Lipid droplets were stained by adding 30 µl of Adi-
poRed (Lonza, Walkersville, MD, USA) per ml of PBS.ture Facility, UCSF). After cryopreservation, cells were
thawed and seeded at 4.5 × 102 cells/cm2. The number of The AdipoRed solution was added to cells growing on
coverslips or chamber slides after washing with PBS andviable cells and cell seeding efficiency were quantified.
Viability was based on trypan blue exclusion and seed- then the cells were incubated at RT for at least 10 min.
Table 1. Antibodies Used in the Study
Target Source Catalog No. Host Type* Application Dilution
GATA-4 Santa Cruz Biotechnology Sc-9053 rabbit pAb IF, FACS 1:50 (IF)
Sox9 Santa Cruz Biotechnology Sc-17341 goat pAb IF, FACS 1:50 (IF)
FSHr ABD Serotec 4561-8019 sheep pAb IF 1:3000 (IF)
CD13 Invitrogen MHCD1301 mouse mAb FACS 1:20
CD14 Invitrogen MHCD1401 mouse mAb FACS 1:20
CD29 Invitrogen CD2901 mouse mAb FACS 1:20
CD31 BD Biosciences 555446 mouse mAb FACS 1:5
CD34 BD Biosciences 348057 mouse mAb FACS 1:5
CD44 Invitrogen MHCD4404 mouse mAb FACS 1:20
CD45 Invitrogen MHCD4501 mouse mAb FACS 1:20
CD73 BD Biosciences 550257 mouse mAb FACS 1:5
CD90 BD Biosciences 555595 mouse mAb FACS 1:50
CD105 Invitrogen MHCD10504 mouse mAb FACS 1:20
CD166 BD Biosciences 559263 mouse mAb FACS 1:5
Gal-1 Rabinovich N/A rabbit pAb IB, IHC 1:3000
*pAb, polyclonal; mAb, monoclonal.
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After rinsing again with PBS, the slides were mounted, using RT2 First Strand kit (SA Biosciences, Frederick,
MD, USA). For reverse transcription of the first-strandand Cy3 fluorescence was visualized on the Nikon
TE2000E epifluorescence microscope (excitation 510– cDNA, the primers were added to 5 µg of total RNA in
a total 20-µl reaction volume. The cDNA solution (1 µl)550 nm and emission 590 nm).
was added to 10 µl of the 2× Fast Cycling PCR mix
Analysis of Endogenous Alkaline Phosphatase Activity (Qiagen) along with 4 µl of the 5× Q solution, and 10
From Myoid Cells µM of the corresponding primer set for a final 20-µl
volume. PCR conditions were 5 min denaturation atTesticular cells (passage 4) growing on glass cham-
ber slides were rinsed with PBS, fixed in 4% PFA in 95°C, followed by 35 cycles at 96°C for 5 s, 55°C or
60°C annealing for 5 s, and extensions at 54–68°C forPBS for 1–2 min, and rinsed with buffered saline solu-
tion. The Vector Red substrate (Vector Labs, Burling- 9 s, with a final extension of 68°C for 5 min. The PCR
products were resolved with either a 1.2% or 2% Sybrame, CA, USA) was prepared according to the manufac-
turer’s instructions. The substrate solution was added to Safe stained E-gel (Invitrogen), and were visualized by a
UV transilluminator equipped with Canon S5 IS digitalthe cells and incubated at RT in the dark for 20–30 min.
After rinsing with buffered saline solution, the slides camera mounted onto a Spectroline portable dark room
system (Spectronics, Westbury, NY, USA).were mounted, and the cells analyzed by light and fluo-
rescence microscopy.
Fluorescence-Assisted Cell Sorting (FACS)
Proliferation and Contact Inhibition For FACS, the antibodies against Sox9 and GATA-4
(gelatin-free; Santa Cruz Biotechnology, Santa Cruz,To further quantify cell proliferation and assess con-
tact inhibition, 0.5 × 103, 1.0 × 103, 2.0 × 103, or 4.0 × CA, USA) were conjugated to allophycocyanin using a
kit (Lightning-Link Allophycocyanin-XL kit, Innova103 (1,500–12,000/cm2) MM-HSE-2305 cells (passage
5) were plated in 96-well tissue culture plates and incu- Biosciences, Cambridge, UK) according to the instruc-
tions of the vendor. Glycerol (60 µl) was added to eachbated at 37°C in a 5% CO2 incubator. The relative num-
ber of cells per well was determined from absorbance vial to extend the shelf life of the antibodies and aliquots
were placed at −80°C for long-term storage. Cells ofdue to the active metabolism of the cell proliferation
reagent WST-1 (Roche, Indianapolis, IN, USA) accord- passage 3–4 were harvested for FACS, centrifuged (800 ×
g for 10 min) to form a pellet with approximately 1 ×ing to the directions of the manufacturer. At 24 h post-
plating the above-mentioned numbers of cells, 10 µl of 107 cells, and the supernatant was removed. The cells
were washed in PBS and a single cell suspension wasWST-1 was added to control wells and the absorbance
was measured 2 h after it was added. The WST-1 absor- formed in 5% cell dissociation buffer, 2% FBS, and
0.05% Triton X-100 by gentle pipetting. Cold (−80°C)bance was measured at 450 nm on a Thermomax micro-
plate reader (Molecular Devices, Sunnyvale, CA, USA). methanol was added (1 ml for 1 × 106 cells) and the cells
were placed at −80°C from 1 h to overnight. After centrif-Total cell numbers were quantified in quadruplicate
wells and defined as 100%. Background from the slight ugation (200 × g for 5 min), the supernatant was removed,
and the cells were incubated with primary antibody orspontaneous absorption of medium alone with WST-1
was subtracted from the reading for each well. At 72 h controls (nonspecific species-matched allophycocyanin-
labeled polyclonal antibody; 0.5 µl APC-antibody con-postplating, another set of quadruplicate wells was ana-
lyzed with WST-1 as above. Proliferation over a 48 h- jugate solution per 0.5–1.0 million cells, or buffer alone)
in 0.5 ml of blocking buffer (PBS with 0.1% Tritonperiod was assessed by comparing the WST-1 absor-
bance of wells analyzed at 24 h to that of wells analyzed X-100 and 5% cell dissociation buffer and 5% species-
specific serum, for example, goat serum with goat anti-at 72 h postplating. The experiment was repeated three
times. Sox9 antibody) in the dark at RT for 1 h. The cells were
washed twice with 2 ml of wash buffer per tube, pelleted
Gene Expression Profiles of Sertoli Cells by RT-PCR by centrifugation (200 × g for 5 min), the supernatant
removed, and, lastly, the cells were suspended in 0.5 mlRT-PCR primer sets were designed to investigate the
mRNA expression profiles of the cells (Table 2) as de- wash buffer for analysis.
For staining cell surface antigens, cells of passagescribed. Total RNA was extracted from MM-HSE-3608
and MM-HSE-1208 cells using an RNeasy minikit from 3–4 were pelleted by centrifugation, and suspended in
1.2 ml of blocking buffer [PBS with 5% normal goatQiagen (Valencia, CA, USA). To assess the RNA qual-
ity, the ratios of r18S to r28S ribosomal RNA were ana- serum, 0.1% bovine serum albumin, 0.01% sodium
azide (Sigma)] and incubated on ice for 10 min. Approx-lyzed on a RNA Nano 6000 chip (Bioanalyzer 2100,
Agilent, Santa Clara, CA, USA), and found to be 1.98 imately 1 × 106 cells were distributed in 100-µl aliquots
into 11 5-ml tubes, and stained with monoclonal anti-and 2.19, respectively. Genomic DNA was eliminated
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Table 2. Sequence of Primers for RT-PCR
Gene Forward Primer Reverse Primer Accession Start End BP T Tm
Sox9 GAGCGAGGAGGACAAGTTC CATGAAGGCGTTCATGGGC 37704387 561 711 151 58 55
GATA-4 CTAGACCGTGGGTTTTGCAT GCAGTCGTCTTCTTTCCAGG 172072611 2188 3030 843 60 60
GDNF GGGCACCTGGAGTTAATGTC TCTGGAATTCTCTGGGTTGG 40549401 124 512 389 60 60
SCF GCTCCAGAACAGCTAAACGG TCTTTGACGCACTCCACAAG 337933 117 533 417 60 60
Oct4 CGTGAAGCTGGAGAAGGAGAAGCTG CAAGGGCCGCAGCTCACACATGTT 12382251 363 607 245 68 60
Nanog GCTTGCCTTGCTTTGAAGCA TTCTTGACTGGGACCTTGTC 13376297 245 500 256 58 55
BMP4 AGCCATGCTAGTTTGATACC CGATCGGCTAATCCTGACAT 576934 147 854 708 54 55
GAPDH ACCCAGAAGACTGTGGATGG TTCAGCTCAGGGATGACCTT 653 777 125 60 60
BP, number of base pairs; T, extension temperature; Tm, annealing temperature.
bodies for CD13, CD29, CD34, CD44, CD73, CD90, Immunohistochemistry of Galectin-1 in Adult Testis
CD105, and CD166 or isotype control mAbs while incu- The expression of galectin-1 in normal human testis
bating on ice in the dark for 30 min. The isotype control was determined by fluorescence immunocytochemistry
monoclonal antibodies were specific to each antibody on cryosections of human testis tissue stained using the
pair (mouse IgG2b PE; BD Biosciences, San Jose, CA, ABC Elite system (Vector Labs). Normal testicular tis-
USA) for CD44 and IgG1 FITC, IgG1 PE (Invitrogen) sue was obtained from the National Disease Research
for the remaining monoclonal antibodies. In addition, Interchange (Philadelphia, PA, USA) and fixed by incu-
monoclonal antibodies to CD13 and CD73 were run in- bation in 3% PFA overnight. Fixed tissue was processed
dependently as FL-1 and FL-2 compensation controls, at the Histology Core of the J. David Gladstone Insti-
respectively. All antibodies were run at approximately tutes (San Francisco, CA, USA) where cryosections
10 µg/ml concentration including isotype controls. The were prepared of 15-µm thickness and collected onto
cells were washed two times in 2 ml FACS wash buffer Superfrost slides. The cryosections were fixed by incu-
(200 × g for 5 min) then fixed in 200 µl of 1% PFA. bation in cold methanol at −80°C for 5 min. The sam-
Data acquisition was performed on 10,000 events per ples were rehydrated with PBS, and blocked with 10%
tube based on a total (ungated) count of forward and horse serum in PBS with 0.1% Triton-X-100 (PBST) at
side light scatter at approximately 200–300 events/s on RT for 30 min, and then with biotin-avidin blocking
a BD FACSort flow cytometer (BD Biosciences) and buffer (Vector Labs) for 30 min. Primary antibody was
analyzed using CELLQuest Pro software (BD Biosci- diluted 1:200 in protein-free blocking buffer and sec-
ences). tions were incubated at 4°C overnight. After washing
with PBST, sections were incubated with biotinylated
Formation of Polarized Sertoli Cell Monolayers
secondary antibody (biotinylated universal anti-IgG of
Transwell inserts (0.4 µm pore size, 0.33 cm2 surface rabbit/mouse/goat) at room temperature for 30 min.
area, PET, Corning, Lowell, MA, USA) were coated After washing again three times with PBST, the sections
with 100 µl of 6.6 µg/ml human fibronectin (BD Biosci- were incubated with DyLight Streptavidin 488 at room
ences) diluted in PBS at RT overnight. Sertoli cells (pas- temperature for 20 min. Finally, the samples and con-
sage 4–5) were harvested and seeded at a cell density trols were washed three times with PBST, mounted, and
of 5 × 105 cells in 300 µl medium in the apical chamber visualized.
with 900 µl medium in the basolateral chamber of each
Immunoblot for Galectin-124-well transwell insert. After 7 days, TER was mea-
sured in three positions on each insert using a MilliCell Sertoli cells (MM-HSE-3608) were seeded onto fi-
bronectin-coated 24-well transwell chambers to formElectrical Resistance System (ERS) epithelial volt ohm-
meter equipped with an Ag/Ag electrode (STX2, World polarized monolayers as described above. Media from
the apical (top) and basal (bottom) chambers were col-Precision Instruments, Sarasota, FL, USA). Raw data
were normalized by subtracting the TER of control ma- lected at 3 and 7 days and analyzed by SDS-PAGE and
immunoblot. Equal volumes of conditioned media fromtrix-coated wells without cells. Experiments also were
performed with Sertoli cells on inserts coated with Ma- the chambers were resolved on 4–12% NuPAGE No-
vex Bis-Tris gel (Invitrogen) with 2-(N-morpholino)trigel (BD Biosciences), and on transwell inserts pre-
coated with collagen I, laminin, or fibronectin (BioCoat; ethanesulfonic acid (MES) SDS buffer at 200 V for 35
min. Proteins were electrotransferred onto 0.2 µm nitro-BD Biosciences).
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624 CHUI ET AL.
cellulose membrane (30 V for 1 h). The transfer effi- processes of variable length extending outward from the
cell bodies (Fig. 1A, B). Their morphology was similarciency was confirmed by Ponceau S staining. After incu-
bation with protein-free blocking buffer (Thermo/Pierce) to that of the Sertoli cells that we previously isolated
from neonatal rats (77).at 4°C overnight, blots were incubated with diluted ga-
lectin-1 polyclonal antibody (1:3,000–1:5,000) at RT for The cells continued to divide until reaching conflu-
ence in the flask, typically after 3–4 weeks, when they1 h, washed with TBS-Tween five times, and incubated
with diluted horseradish peroxidase (HRP) 1:5,000–1: were passaged (4.5 × 102 cells/cm2). In general the mor-
phology of the cells was unchanging with passage as10,000 at RT for 1 h. After washing five times with
TBS-Tween, the blot was rinsed in water, developed can be seen by comparing MM-HSE-3608 cells from
passage 2 (Fig. 1A) and passage 4 (Fig. 1B); however,with TMB and membrane enhancer (KPL). Images were
captured with a digital camera and digitally enhanced the average cell size appeared to increase slightly. It was
confirmed that after cryopreservation, cells of low pas-(Adobe PhotoShop or ImageJ).
sage number (passage 1–5) could be refrozen, thawed,
Effect of Conditioned Medium From Human Sertoli and replated.
Cells on Lymphocyte Proliferation Ultrastructural analyses also revealed morphology
Conditioned media were collected from MM-HSE- consistent with that of Sertoli cells (Fig. 1C–F). The
2305 and human foreskin fibroblast (control) cell line large irregularly shaped nuclei of most cells had promi-
Hs27 (CRL-1634; ATCC, Manassas, VA, USA) cultures nent nucleoli. Other features typical of Sertoli cells
at 70–80% confluency at 48 h postplating. The experi- could be observed including lipid droplets, abundant
ments were performed in a 96-well plate. Each assay smooth and rough endoplasmic reticulum, and perin-
well had a total volume of 120 µl, with 1 × 104 human ucleolar spheres.
lymphocytes (ATCC; Jurkat E6-1, TIB-152) maintained
Cells Exhibit Contact Inhibition and Proliferatein RPMI-1640 media with 15% FBS, 1× penicillin-
in Culturestreptomycin) with varying amounts of either Sertoli or
Hs27 fibroblast conditioned media or unconditioned me- Three separate analyses of viability, seeding effi-
dium (serving as controls). The 96-well plate was incu- ciency, and division rate (Table 3) were performed after
bated at 37°C in a 5% CO2 incubator for 72 h. The rela- cryopreservation of vials of cells isolated from tissues
tive proliferation of the lymphocytes in each well was from two donors, termed MM-HSE-3608 (passage 2)
then determined by active metabolism of WST-1. After and MM-HSE-2305 (passage 3) as described in Materi-
2–4 h of incubation with 12 µl of WST-1 according to als and Methods. Cryopreserved cells retained about
the directions of the manufacturer, the absorbance was 90% viability, 83% seeding efficiency, and had an aver-
measured at 450 nm. The absorption of the medium age division rate of 4 days. The results presented (Table
alone with WST-1 defined as background was sub- 3) are the mean ± SD of independent assays of three
tracted from the reading for each well. vials of cryopreserved MM-HSE-2305 and MM-HSE-
3608 cells with duplicate or triplicate analyses. The cells
Statistical Analyses retained the ability to proliferate after prolonged cryost-
Multiple group comparisons were analyzed by one- orage (>30 months) and multiple freeze–thaw cycles.
and two-way ANOVA followed by Bonferroni’s post A doubling rate of approximately 4 days was also
hoc analysis (GraphPad Prism, Version 4.03). Within- determined by quantifying and comparing the number of
group comparisons were done using two-tailed t-tests. metabolically active cells in 96-well plates at 24 and 72
Data are expressed as mean ± SD. Significance was de- h postplating (Fig. 2). Contact inhibition was observed
fined at p < 0.05. as when plated at high densities (4 × 103 cells/well), the
cells did not proliferate, thereby demonstrating theirRESULTS
nontransformed nature. The cells maintained contact in-
Sertoli Cell Isolation and Ultrastructural Characterization hibition after multiple passages and prolonged culture.
The incorporation of EdU (Invitrogen) into the nu-At 2–20 days postisolation from the testis tissue, a
few thin cells were observed adherent to the bottom of cleus of dividing cells over a 3-day period was used
to assess cell proliferation directly. MM-HSE-3608 cellsculture flasks. Initially, less than approximately 20 dis-
tinct colonies of cells were apparent with each colony (passage 6) were incubated with EdU that was incorpo-
rated into DNA during active synthesis. Fluorescent de-comprising only a few cells. The numbers of cells within
the colonies expanded beyond what was seen within the tection was enabled by reaction of the EdU-conjugated
alkyne with azide linked to Alexa-Fluor 594 (Click-iTfirst several days after plating, consistent with cell pro-
liferation. Cells typically assumed polygonal phenotypes EdU, Invitrogen). Phase contrast images showed the cell
boundaries were overlaid with fluorescence images (Fig.with irregularly shaped nuclei and several filamentous
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Figure 1. Morphology consistent with Sertoli cells shown by cultured cells. Phase contrast micros-
copy of MM-HSE-3608 cells of passage 2 (A) and passage 4 (B) reveals features characteristic of
Sertoli cells including branching cytoplasmic processes and irregularly shaped nuclei. Electron
microscopy of MM-HSE-2305 cells of passage 2 (C–F) clearly shows the irregularity of the shape
of the nucleus (NM; nuclear membrane) in addition to the prominent nucleolus (Nu). Lipid droplets
(L) and abundant rough (R) and smooth (S) endoplasmic reticulum are evident within the cyto-
plasm (D, E). Dense chromatin (DC) is apparent along the nuclear envelope (F). Scale bars: 200
µm (A, B), 2.3 µm (C), 750 nm (D), 500 nm (E, F).
Delivered by Ingenta to: Universidad San Andres
IP: 168.96.251.98 On: Wed, 04 Jan 2017 19:58:58
Article(s) and/or figure(s) cannot be used for resale. Please use proper citation format when citing this article including the DOI,
publisher reference, volume number and page location.
626 CHUI ET AL.
Table 3. Cryopreserved Vial Analysis localized to the nucleus as expected for a transcription
factors whereas FSHr staining also as expected was cy-
Assay 3608 P2 2305 P3 toplasmically localized.
Alkaline phosphatase is expressed by the peritubularViability (%) 88.0 ± 5.41 91.1 ± 3.87
myoid cells but not Sertoli cells (2). However, relativelySeeding (%) 83.3 ± 10.2 83.0 ± 9.90
few myoid cells were stained for endogenous alkalineDivision (day) 4.51 ± 0.35 3.32 ± 0.35
phosphatase activity as illustrated in Figure 3E, and the
Duplicates in three separate experiments with ±SD. Trypan blue exclu-
number of stained cells diminished with increasing pas-
sion for viability; divisions of >9 twice plating 450 cells/cm2. P, pas-
sage. These data alleviated a concern that myoid cellssage number.
could overtake the cultures in the FBS-containing growth
medium.
3A), revealing that the majority of nuclei were stained
MM-HSE-2305 Cells Express Several Genes Typicalred, indicating incorporation of EdU.
of Sertoli Cells
Immunological and Histological Analyses RT-PCR analysis of MM-HSE-2305 cells revealed
The presence of lipid droplets is a salient feature of that they expressed several typical genes previously
Sertoli cells from humans (51,58) and other mammalian shown to be expressed by Sertoli cells. Consistent with
species (31) that can be easily detected by the Oil red previously published results, the human Sertoli cells ex-
O-based method (81) (Lonza). The presence of lipid is pressed stem cell factor (SCF) (57,67), glial cell line-
shown by lighter spots of various sizes in the cytoplasm derived neurotrophic factor (GDNF) (11,26), and bone
of cells in the grayscale image in Figure 3B. The appear- morphogenic protein 4 (BMP4) (27). GAPDH, a house-
ance of the droplets is similar to that observed in murine keeping gene, was used as a control (5). The PCR prod-
Sertoli cells in coculture with germ cells (81). uct sizes (Fig. 4) matched computer predictions from
Isolated cells were found to express GATA-4 (Fig. NCBI sequence data. Lane 1 presents analysis of MM-
3C) and FSHr (Fig. 3D). High and low concentrations HSE-3608 cells, and lane 2 of MM-HSE-1208 cells. No
of primary antibodies demonstrated dose-dependent speci- PCR products were detected in the no-RNA control
ficity and antigen-specific staining patterns. GATA-4 was sample (data not shown).
Flow Cytometric Analysis Reveals Expression
of Sertoli Cell Markers
The results from flow cytometry of human Sertoli
cells from two different donors, MM-HSE-3608 (pas-
sage 3) and MM-HSE-2305 (passage 4) cells were very
similar (Fig. 5A, B). The cells positively staining for
GATA-4 and Sox9 in 3608 and 2305 were more than
99% of the population confirming the Sertoli cell iden-
tity of most cells. Similarly, flow cytometric analysis
of MM-HSE-1208 (passage 4) and MM-HSE-1509 cells
(passage 4) isolated from two other donors revealed that
98.7% and 97.5% expressed Sox9, respectively, and
95.5% and 96.9% of the cells expressed GATA-4, re-
spectively (data not shown).
The MM-HSE-3608 and MM-HSE-2305 cells were
Figure 2. Percentage increase in number of Sertoli cells (MM- negative for CD34 (4% and 6%, respectively), which is
HSE-2305; P5) at 72 h postplating compared to the number of expressed by hematopoietic and endothelial progenitor
cells in control wells at 24 h postplating. There was a signifi-
cells (71), and were of mixed expression for CD13 (82%cant difference in the proliferation of the cells (indicated by
and 95%, respectively), CD90 (98 and 70%, respectively),bar, p < 0.0001) plated at 1.0 or 2.0 × 103 cells per well and
those that were plated at 4.0 × 103 cells per well based upon and CD166 (82% and 99%, respectively). Interestingly,
one-way ANOVA. The number of cells initially plated (as- the two populations, MM-HSE-3608 and MM-HSE-
sessed at 24 h) at 1.0 and 2.0 × 103 cells per well increased 2305, were almost uniformly expressive of a number of
significantly by almost 50% over 48 h (**p = 0.004). The re-
markers: CD29 (99 and 100%, respectively), CD44 (98sults are the mean of two independent experiments with qua-
and 99%, respectively) CD105 (98 and 99%, respec-druplicates, and are representative of three independent experi-
ments. tively), and CD73 (98 and 99%, respectively).
Delivered by Ingenta to: Universidad San Andres
IP: 168.96.251.98 On: Wed, 04 Jan 2017 19:58:58
Article(s) and/or figure(s) cannot be used for resale. Please use proper citation format when citing this article including the DOI,
publisher reference, volume number and page location.
PROLIFERATIVE HUMAN SERTOLI CELLS 627
Figure 3. Immunochemical staining reveals cell proliferation, expression of characteristic Sertoli cell markers, and few myoid cells.
Fluorescent microscopy of MM-HSE-3608 (passage 6) cells after treatment with 2 µM EdU for 3 days (A) demonstrates nuclear
uptake of EdU in almost all cells. Fluorescence microscopy of MM-HSE-2305 cells (passage 4) stained with AdipoRed reveals
bright spots shown in grayscale that are indicative of lipid droplets (B). Immunostaining of HSE-MM-2305 cells (passage 3) for
GATA-4 (C) demonstrates the expected nuclear expression pattern, whereas bisbenzamide (Hoescht) dye (blue) staining of nuclei
and immunostaining for FSHr (D) is consistent with its expected cytoplasmic localization. Low detection of Vector Red from
alkaline phosphatase activity (E) demonstrates that there are few myoid cells in the culture. Two red-stained myoid cells can be
observed. Scale bars: 100 or 200 µm as indicated.
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or thin layers of Matrigel resulted in contraction and
spheroid formation. The cells growing on fibronectin-
coated transwell inserts were the only ones that were not
visibly contracted from the edge of the insert, and also
produced the highest TER values. As illustrated in Table
4 with MM-HSE-3608 cells (passage 4), growing the
Sertoli cells on transwell inserts that were coated with
fibronectin resulted in noncontracted layers forming
tight junctions that reached an average of 137.1 ohms/
cm2 at 7 days postplating. The data are representative of
three independent experiments. These TER values are
similar to those reported when tight junctions were
formed by rodent Sertoli cells in transwell systems in
the absence of FSH and testosterone supplementation ofFigure 4. RT-PCR confirms cellular expression of genes that
the medium (9,29).are characteristic of Sertoli cells. Lane 1 is MM-HSE-3608
The formation of tight junctions was also assessed bycells; 2 is MM-HSE-1208.
analyses of polarized secretion of protein. Conditioned
media from apical and basolateral chambers of transwell
Immunohistochemistry of Galectin-1 in Human Testis inserts seeded with Sertoli cells were collected after 3
and 7 days and the expression of galectin-1 was ana-Microphotographs of cryosections of normal adult
lyzed by SDS-PAGE followed by immunoblot. The re-testis stained with hematoxylin and eosin (Fig. 6A) show
sults revealed (Fig. 7) that the galectin-1 concentrationthe structural architecture of the tubule. Sertoli and sper-
was higher in the medium from the apical compared tomatogonial stem cells are surrounded by peritubular my-
the basolateral chambers at both 3 and 7 days, and dem-oid cells, various stages of the differentiating germ cells
onstrated the integrity of the barrier formed by the tightfill the lumen, and Leydig cells are located in the inter-
junctions of the confluent cells in the inserts.stitial spaces between tubules. High levels of galectin-1
staining (green) can be observed in cryosections immu-
nostained with galectin-1 antibody (Fig. 6B) associated Conditioned Medium From Human Sertoli Cells
with the peritubular cells on the edge of the tubules, and Inhibits Lymphocyte Proliferation
within the tubules associated with both differentiating To ascertain whether human Sertoli cells secrete im-germ cells and Sertoli cells. Galectin-1 expression is of
munosuppressive factors, conditioned medium was pre-particular interest due to its immunosuppressive activity pared from MM-HSE-2305 cells (passage 4), and the(28,52,55,73,74).
effect on human T lymphocytes (Jurkat E6-1 cells) was
evaluated in a proliferation assay. There was a signifi-MM-HSE-3608 Human Sertoli Cells Display Polarity
cant (p < 0.001) dose-responsive decrease in the prolif-as Observed in Testes
eration of human T lymphocytes incubated with variousTo establish an in vitro human Sertoli BTB model,
concentrations of human Sertoli cell conditioned media
cells were seeded on semipermeable 24-well transwell
compared to cells exposed to the same concentrations ofinserts coated with fibronectin. Precoated collagen I,
medium conditioned by HS27 human foreskin fibroblastlaminin, and fibronectin transwell inserts, uncoated in-
cell conditioned medium (Fig. 8). More than 50% of the
serts, and inserts coated with thick (150 µl) or thin (30 proliferation was inhibited with the highest concentra-µl) layers of Matrigel also were tested. The effect of
tion of Sertoli cell conditioned medium.
changing parameters such as different pore sizes (0.4,
1.0, 3.0, and 8.0 µM), cell seeding densities, and growth
DISCUSSIONmedia with and without FBS were examined. To com-
pare the formation of tight junctions under the various We provide the first evidence that a small population
of proliferative human Sertoli cells isolated from adultconditions, the transwell inserts were assessed visually
by observation of unequal levels of media in the apical human testes can be expanded in vitro while retaining
expression of characteristic markers and exhibiting pro-and basolateral chambers of the transwells, by detection
of the polarized secretion of protein, and by measure- totypical functionality. In vivo Sertoli cells create the
BTB that consists of specialized junctions, includingment of TER that is correlated positively with a more
impenetrable barrier. The major problem encountered tight junctions, basal ectoplasmic specializations, and
desmosome-like junctions. This report also is the firstwas that the Sertoli cells tended to separate from the
edges of the insert and curl up. The use of either thick to describe establishment of a tight junction barrier, a
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Figure 5. Flow cytometry shows more than 90% of cells at passage 3–4 express the Sertoli cell markers GATA-4 and Sox9, and
less than 7% express CD34, a marker for hematopoietic and endothelial progenitor cells. Gray histograms showing antibodies
staining of MM-HSE-3608 (A) and MM-HSE-2305 (B) cells for CD13, CD29, CD34, CD44, Sox9, CD73, CD90, CD105, CD166,
and GATA-4 compared to that of isotype control antibodies (white histograms). The percentage of cells positively stained for each
antigen is shown.
characteristic function of Sertoli cells, by isolated hu- the Sertoli cell tight junctions are formed adjacent to
the basement membrane near the underlying myoid cellsman Sertoli cells in vitro.
The primary human Sertoli cells were plated at high (41,65). In future studies, we plan to image proteins
comprising the tight junctions in the polarized humandensity onto transwell inserts coated with human fibro-
nectin, an extracellular matrix protein secreted by testic- Sertoli cells (84,85), and test the effect of FSH and tes-
tosterone supplementation on the barrier function. Thisular peritubular myoid cells but not by Sertoli cells
(66,78). The human fibronectin facilitated the formation system, when fully characterized, might prove to be a
valuable tool as a BTB model for testing the toxicityof stable, polarized cell monolayers that over time devel-
oped a tight junction–permeability barrier as shown by and penetration of chemicals and drugs, and as an aid in
achieving human in vitro spermatogenesis.an increase in TER and by the polarized secretion of
galectin-1. These data suggest that the polarized Sertoli We analyzed expression of cell surface markers be-
cause identification of such markers specific for Sertolicells were oriented so that the apical compartment of
the transwells corresponded to the adluminal side of the cells could facilitate their purification. The Sertoli cell
markers GATA-4 and Sox9 are nuclear and thereforeSertoli cell barrier because in the seminiferous tubule
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Figure 6. Immunocytochemistry of human testes sections reveals expression of galectin-1. Photo-
micrographs of cryosections of normal adult testis stained with hematoxylin and eosin (A), and
immunostained with galectin-1 antibody (B). The hematoxylin and eosin-stained cross section of
the seminiferous tubule (A) shows the structural architecture of the tubule in which Sertoli and
spermatogonial stem cells are surrounded by peritubular myoid cells, and germ cells fill the lumen.
Leydig cells are located in the interstitial spaces between the tubules. High levels of galectin-1 (B)
staining (green) can be observed on the perimeter of the tubule, and within the tubules associated
with both Sertoli cells and differentiating germ cells. Scale bars: 50 µm.
not useful in purification of living cells. The Sertoli cells
expressed several cell surface antigens that are involved
in proliferation and motility, including CD166 (activated
leukocyte cell adhesion molecule or ALCAM), which is
primarily found on subsets of cells undergoing robust
growth or migration (47,70), CD105 (endoglin), an
accessory component of the receptor complex of trans-
forming growth factor-β (TGF-β), indicative of prolifer-
ation in endothelial cells (19), and CD13, or aminopepti-
dase N (43). Other cell surface antigens detected such
as CD29 (integrin β-1), CD44 (hyaluronan/fibronectin
or MIP-1β receptor), and CD90 (Thy-1) are adhesion
molecules involved in cell–extracellular matrix or cell–
cell interactions. Interestingly, CD13, CD29, CD44,
CD73, CD90, CD105, and CD166 are thought to be
characteristic markers for multipotent mesenchymal
cells (14,40). GATA4 (32) and Sox9 (6,7) are expressed
by some populations of mesenchymal stem cells. CD90
has been localized to human spermatogonia (24), and
has been employed in isolation of spermatogonial stem
cells (10). However, as shown our data indicate, CD90
Figure 7. A Ponceau S-stained blot (upper) of conditioned me-is also expressed by human Sertoli cells, and therefore
dia from the apical (A lanes) and bottom (B lanes) transwell
chambers containing a monolayer of Sertoli cells on cell cul-
ture inserts at 3 and 7 days postplating with MW markers (M
lane) on the left side is presented. Greater apical (top chamber)Table 4. TER of Transwell Inserts
secretion was detected of an unidentified protein running near
the 260-kDa marker on the Ponceau S-stained loading controlWell TER/cm2 SD
blot (top arrow). Growth medium only as a negative control is
shown in lane C. In the immunoblot (lower) greater secretion1 136.4 15.5
of galectin-1 into conditioned media from apical (A lanes)2 138.5 4.62
compared to bottom chamber (B lanes) from transwells at 33 136.4 27.2
and 7 days postplating is revealed by the bands that are atMean 137.1 15.8
approximately 14.5 kDa (bottom arrow).
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firming the previously reported cytoplasmic and nuclear
expression of galectin-1 by human Sertoli cells (83). The
perimeter of the seminiferous tubule where the peritubu-
lar cells are located appeared to have the greatest con-
centration of galectin-1. Fibronectin, which is secreted
by the peritubular myoid cells (78), has been found to
be a ligand of galectin-1 (50).
The immunosuppressive properties of galectin-1, in-
cluding the ability of this glycan-binding protein to reg-
ulate dendritic cell physiology and T cell fate, have been
well established (55). Thus, the data suggest that galec-
tin-1 could potentially have an active role in conferring
an immune-privileged status to the human testis.
Although it has long been thought that mammalianFigure 8. Conditioned media from human Sertoli cells sup-
press lymphocyte proliferation. Proliferation of lymphocytes Sertoli cells do not divide postpuberty (48,49,62), re-
was significantly decreased by conditioned media from MM- cently this view has been challenged (1,75). Our results
HSE-2305 Sertoli cells (two-way ANOVA, p < 0.001) com- show that human adult Sertoli cells retain the ability topared to HS-27 conditioned medium. Values represent the divide postpuberty and possess immunoregulatory ac-mean ± SD and are from three separate experiments with each
tivity.concentration tested in triplicate.
Proliferation of adult murine Sertoli cells in vitro in
the absence of specific hormonal supplementation was
found to be associated with a 70% decrease in expres-would not be selective for a pure population of sperma-
togonial stem cells. sion of the cell cycle inhibitor CDKN1B (P27kip1) and
a twofold increase in the levels of the proliferation in-Expression of alkaline phosphatase, which is indica-
tive of peritubular myoid cells, was observed at very low ducer ID2 (1). Whether adult Sertoli cells resumed pro-
liferation in vitro in the absence of specific hormonelevels, with decreased staining with increasing number
of cell passages. Possibly, the culture could be selec- supplementation or if we isolated a subpopulation of
Sertoli cell progenitor cells is not clear. In rats FSH hastively enriched for the Sertoli cells because the alkaline-
phosphatase-positive peritubular myoid cells are more been shown to affect Sertoli and germ cell proliferation
in an age-dependent manner (42). Our data appear con-adhesive to cell culture ware or divide more slowly than
Sertoli cells. sistent with results from a study of Sertoli cell differenti-
ation in adult Djungarian hamsters that included analy-The results provide evidence in support of active im-
munosuppession in the human testis. Indeed, in vitro ses of cell proliferation, localization of junctional proteins,
and expression of maturation markers and found thecultured human Sertoli cells retained immunosuppres-
sive capability, as their conditioned media inhibited the adult Sertoli cells were not terminally differentiated but
existed in a transitional state, exhibiting both undifferen-proliferation of T lymphocytes. The inhibitory effect of
the primary human Sertoli cell conditioned media on the tiated and differentiated features (72). Our results sug-
gest that the proliferative adult human Sertoli cells mayproliferation of human Jurkat E.6 T lymphocytes was
similar in magnitude to that we observed with rat T lym- share some characteristics with mesenchymal stem cells.
Recently, a putative population of mesenchymal stemphocytes and rat Sertoli cell conditioned media (76). The
data also are in accordance with previous reports of the cells was isolated from adult human testes that when
cultured using specific differentiation medium differen-inhibition of proliferation of lymphocytes by rodent Ser-
toli cell conditioned media (12,60). Evidence of active tiated into adipogenic, osteogenic, and chondrogenic
cells (21) exhibiting broad plasticity. The testicular mes-immunosuppression by our primary human Sertoli cells
may be especially important for potential therapeutic ap- enchymal cells expressed CD105, CD166, CD73, and
CD90, and had morphology similar to that of the func-plications because data from animal studies indicate that
Sertoli cell lines lack immunosuppressive properties tional primary human Sertoli cells.
Culture conditions including confluency, transmem-(15).
Our description of the polarized expression of galec- brane potential, growth hormones, extracellular matrix,
and other characteristics of the microenvironment affecttin-1 by the human Sertoli cells corroborates the previ-
ous observation of the regulated expression of galectin- cell differentiation (3,54,69,80). Our results demonstrate
that after isolation and culture under the conditions de-1 during the spermatogenic cycle of rats (13). We also
observed localization of galectin-1 in vivo in the adlumi- scribed, the proliferative primary human testicular cells
exhibit characteristics specific to human Sertoli cells,nal compartment of the human seminiferous tubule, con-
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